The global single-use filtration market is set to reach USD 3.53 billion in 2023. By 2033, the market valuation is forecast to cross USD 19.28 billion, with a CAGR of 18.5%.
Due to the increased significance of maintaining sterile conditions, numerous biopharmaceutical businesses choose single-use filtration assemblies for final and bulk-fill processes. A rise in life sciences research and development activities provides excellent opportunities to single-use filtration assembly manufacturers.
Reduced danger of cross-contamination and faster implementation have all contributed to the amazing sales of single use filtration assemblies for biopharma.
More demand for tailored treatments, smaller batch sizes, and the requirement for adaptable and scalable solutions are key drivers thriving the adoption of single-use technologies in the pharmaceutical business.
Single-use filtering systems offer a high level of adaptability and agility, enabling rapid and simple adjustments to shift requirements. Single-use filtering systems are flexible and inexpensive, and this combination is expected to fuel industry expansion.
| Attributes | Details |
|---|---|
| Single-use Filtration Assemblies Market CAGR (2023 to 2033) | 18.5% |
| Single-use Filtration Assemblies Market Size (2023) | USD 3.53 billion |
| Single-use Filtration Assemblies Market Size (2033) | USD 19.28 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Their capacity to offer a contamination-free alternative to conventional stainless steel systems has led to a boom in market acceptance. These filtration assemblies are created by welding and employing reinforced tubing, so no associated validation procedures or sterilization procedures are required. This leads to a growth of around 1.18x between 2022 and 2023.
| Attributes | Details |
|---|---|
| Market Size (2018) | USD 1.45 billion |
| Market Size (2022) | USD 2.98 billion |
| Market CAGR (2018 to 2022) | 19.8% |
The single-use filtering assemblies sector is expanding owing to the rise in biopharmaceutical CMOs (Contract Manufacturing Organizations). These companies require scalable, adaptable manufacturing systems that are flexible enough to meet shifting production demands.
Key competitors in the global market are paying more attention to the development and marketing of technologically cutting-edge single-use assembly products with streamlined workflows, straightforward operation, and quick deployment.
Principal Consultant
Making sure that quality and uniformity are maintained throughout several batches is one of the key milestones the market is experiencing. The performance of the assembly may vary as a result of the use of various raw materials, manufacturing techniques, and suppliers, which have an impact on the effectiveness and quality of the finished product.
Concerns regarding the environmental effects of single-use plastic items have been sparked by the growing adoption of single-use filtration assembly. The single-use filtration assembly business is expanding, thus the sector needs to develop strategies to cut waste and advance sustainability.
In 2022, North America held the leading market share of 36.4%. The United States is expected to lead the market with a CAGR of 14.9% by 2033. The region's market is expanding as a result of the well-developed healthcare system and rising demand for biopharmaceuticals.
The market has expanded as a result of the existence of numerous important players in the United States, including Pall Corporation, Sartorius AG, Thermo Fisher Scientific, and Merck. To take advantage of the increasing demand for single-use filtration assemblies in the area, these businesses are consistently making investments in their manufacturing facilities, boosting their product portfolios, and establishing business alliances.
To meet the rising demand for biotechnology solutions, for instance, Pall Corporation and Cytiva invested USD 1.5 billion in July 2021. This increased production of vital products used to make biologics, such as single-use technologies like bioreactor bags and syringe filters, increases the supply of biologics. The market in the United States is anticipated to grow as a result of such investments.
The growth of the biopharmaceutical sector is being encouraged by the government and regulatory agencies, which is anticipated to increase demand for single-use filtration assemblies. For market participants who are active in this sector, this offers enormous prospects.
For instance, China's NMPA approved 16 new medications in September 2022, comprising 12 chemical medications and 4 biological goods.
Avantor purchased RIM Bio, a Chinese firm that makes single-use assemblies and bioprocess bags for the manufacturing of biopharmaceuticals, in June 2021. Via this acquisition, Avantor got access to the RIM plant in Changzhou, which served as one of the company's earliest single-use manufacturing facilities in the AMEA area.
These occurrences result in a rising usage of single-use filtration assemblies across various geographies, which is anticipated to fuel market expansion.
India is expected to develop at a CAGR of 14% during the forecast period. The manufacture of biosimilars and other complicated biologics, as well as increased investments in research and development, have all contributed to the recent rapid growth of the Indian pharmaceutical sector. The demand for cutting-edge filtration technologies, such as single-use filter assemblies, is being driven by this.
Initiatives to proliferate Indian Market are:
Europe is anticipated to expand moderately during the next few years. It had a market share of 29% in 2022. Also, the United Kingdom is one of the prominent markets in Europe and is expected to provide lucrative opportunities during the forecast period.
In the study, market growth is attributed to elements including the rising usage of single-use technologies in the biopharmaceutical sector, the rising demand for biologics and biosimilars, and the emphasis on lowering manufacturing costs and boosting productivity.
However, there are now considerable uncertainties and difficulties in the United Kingdom market as a result of Brexit and its aftereffects. Questions concerning trade and regulatory alignment have been highlighted by the United Kingdom's exit from the European Union, which may have an effect on the country's single-use technology uptake and the biopharmaceutical sector.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In 2022, the membrane filtration market had the leading share, with about 47.8%. The growing usage of filtering systems by numerous sectors is responsible for this growth. Moreover, the expansion of the biopharmaceutical sector has led to a rise in the demand for TFF in recent years.
The introduction of fresh single-use TFF systems has further expedited this market's growth. For instance, ABEC, Inc. unveiled a new single-use TFF system in September 2021 with the intention of boosting downstream production through quicker processing times and higher flow rates.
The depth filtration segment is expected to register a significant CAGR of 19.15% from 2023 to 2033. This is due to its exceptional performance in terms of high throughput, low protein binding, and high dirt-holding capacity.
With a market share of over 41.6% and a significantly growing revenue share in 2022, the bioprocessing/biopharmaceuticals market category led the industry. The creation of biopharmaceutical goods is receiving more financing for research and development, which is the cause of this rise.
For instance, the NIIMBL (National Institute for Innovation in Manufacturing Biopharmaceuticals) of the United States provided USD 3 million in funding for 6 new biopharmaceutical manufacturing projects in October 2021.
With a share of 21.1% in 2022, the filter segment was the market leader. One of the most well-liked and frequently applied single-use technologies is the single-use filter. The use of flocculating chemicals, filter aids, and protective profilers can improve the effectiveness of depth filters during clarity procedures.
Merck Millipore and Sartorius both employ these strategies. Moreover, automation in filtration techniques is anticipated to fuel market expansion. Also, to clarify microbial and mammalian cell-based biopharmaceuticals, the Indian Institute of Technology (Delhi) has created an automated approach for continuous depth filtration employing a dead-end filtering skid.
The leading players in the single-use filter assemblies sector are engaged in fierce competition, which is only predicted to get worse as single-use technologies are increasingly adopted by the biopharmaceutical sector.
The businesses are also spending money on research and development to create cutting-edge single-use filter assemblies that perform and operate more effectively than their conventional equivalents.
The manufacturers' shift in emphasis from small-molecule pharmaceuticals to large-molecule drug products is accelerating the market's growth rate. One of the key elements fueling the market's expansion for single-use filtration assemblies is the increased accessibility of life science investment funds.
Recent Development:
The single-use filtration assemblies market is set to reach USD 3.53 billion in 2023.
The single-use filtration assemblies market is likely to surge at an extraordinary 18.5% CAGR, reaching USD 19.28 billion by 2033.
Key factors propelling the surge in demand for single-use filtration assemblies include technological advancements, cost-effectiveness, and operational efficiency.
Between 2018 and 2022, the global single-use filtration assemblies market witnessed a remarkable CAGR of 19.8%, elevating its value from USD 1.45 billion to USD 2.98 billion.
The United States, fueled by its expansive biotech sector, presents substantial profit potential for single-use filtration assemblies, with a 14.9% CAGR through 2033.
1. Executive Summary | Single-use Filtration Assemblies Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 5.1. Membrane Filtration 5.2. Depth Filtration 5.3. Centrifugation 5.4. Others 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Pharmaceuticals Manufacturing Market 6.2. Bioprocessing/Biopharmaceuticals Market 6.3. Laboratory Use 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 7.1. Filters 7.2. Cartridges 7.3. Membranes 7.4. Manifold 7.5. Cassettes 7.6. Syringes 7.7. Others 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. South Asia 8.5. East Asia 8.6. Oceania 8.7. MEA 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Sartorius AG 18.2. 3M Purification 18.3. Danaher 18.4. Repligen Corporation 18.5. Merck Millipore 18.6. Cellab 18.7. Medela 18.8. Thermo Fisher Scientific, Inc. 18.9. MEISSNER FILTRATION PRODUCTS, INC. 18.10. Dr. Mueller AG 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Industrial Automation Insights
View Reports
Single-use Filtration Assemblies Market
